These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6803570)

  • 21. [Clinical manifestations of the anticoagulant lupus factor. Apropos of 2 cases and review of the literature].
    Olalla Antolín JJ; Trugeda Padilla A; Martín Durán R; Bardají Mayor JL; Larman Tellechea M; Otero Fernández M
    Rev Esp Cardiol; 1986; 39(2):163-5. PubMed ID: 3088686
    [No Abstract]   [Full Text] [Related]  

  • 22. Recurrent venous thrombosis with a "lupus" coagulation inhibitor in the absence of systemic lupus.
    Manoharan A; Gibson L; Rush B; Feery BJ
    Aust N Z J Med; 1977 Aug; 7(4):422-6. PubMed ID: 270997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lupus anticoagulant.
    Perico N; Pusineri F; Remuzzi G
    Proc Soc Exp Biol Med; 1984 Sep; 176(4):337-41. PubMed ID: 6431412
    [No Abstract]   [Full Text] [Related]  

  • 24. Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant.
    Averbuch M; Levo Y
    Ann Rheum Dis; 1986 May; 45(5):435-7. PubMed ID: 3087300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus.
    Edwards RL; Rick ME; Wakem CJ
    Arch Intern Med; 1981 Nov; 141(12):1688-90. PubMed ID: 6171218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lupus anticoagulant as a risk factor of thrombosis].
    Lewandowski K; Zawilska K
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):154-5. PubMed ID: 1437806
    [No Abstract]   [Full Text] [Related]  

  • 27. Fletcher factor deficiency (Report of a new case).
    Colla G; Carrea M; Sbaffi A
    Ric Clin Lab; 1983; 13(4):443-8. PubMed ID: 6558774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for thrombosis in lupus patients.
    Hasselaar P; Derksen RH; Blokzijl L; Hessing M; Nieuwenhuis HK; Bouma BN; De Groot PG
    Ann Rheum Dis; 1989 Nov; 48(11):933-40. PubMed ID: 2512863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural inhibitors of blood coagulation and fibrinolysis in patients with lupus anticoagulant.
    Kordich LC; Forastiero RR; Basilotta E; Porterie P; Carreras LO
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):765-71. PubMed ID: 1489897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete prekallikrein deficiency masquerading as a lupus anticoagulant.
    Moore GW; Sangle SR; Archer RA; Maloney JC; Rahman A; D'Cruz DP
    Thromb Res; 2014 Feb; 133(2):301-2. PubMed ID: 24315318
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lupus anticoagulant].
    Huang ZL
    Zhonghua Nei Ke Za Zhi; 1988 May; 27(5):318-21. PubMed ID: 3143524
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.
    Hughes GR
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1088-9. PubMed ID: 6414579
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lupus anticoagulant--its role and significance in the pathogenesis of thrombosis].
    Styczyńska M; Chojnowski K; Matusewicz W; Krykowski E
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):151-3. PubMed ID: 1437805
    [No Abstract]   [Full Text] [Related]  

  • 35. The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension.
    Anderson NE; Ali MR
    Ann Rheum Dis; 1984 Oct; 43(5):760-3. PubMed ID: 6437349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lupus-type anticoagulants and thromboses].
    Sultan Y
    Ann Med Interne (Paris); 1986; 137(6):475-6. PubMed ID: 3101565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis.
    Freyssinet JM; Wiesel ML; Gauchy J; Boneu B; Cazenave JP
    Thromb Haemost; 1986 Jun; 55(3):309-13. PubMed ID: 3018955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.
    Carreras LO; Vermylen JG
    Thromb Haemost; 1982 Aug; 48(1):38-40. PubMed ID: 6813993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gangrene developing after minor surgery in a patient with undiagnosed systemic lupus erythematosus and lupus anticoagulant.
    Jindal BK; Martin MF; Gayner A
    Ann Rheum Dis; 1983 Jun; 42(3):347-9. PubMed ID: 6407406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.